戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (rifght1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                                  Five (15%) patients had 11 grade 3 treatment-related adverse events; no
2                                                    Six (3%) patients had 11 serious adverse events: one (2%) patient in t
3 ment assignment accounting for nonindependence of eyes when patients had 2 uveitic eyes.
4 edly reduced rod and cone responses, but nonsyndromic USH2A patients had 30 Hz-flicker electroretinogram amplitudes that
5                                        Within 30 days, CABG patients had a 25-fold, a 26-fold, and a 18-fold higher risk
6                                   11 (18%) of 60 assessable patients had a confirmed objective response, including ten (3
7                                                     Younger patients had a higher likelihood of complete clinical success
8                                              A total of 283 patients had a serious infection; the incidence rates with 95
9                                             36 (10%) of 370 patients had a serious treatment-related adverse event.
10                                                    Eligible patients had a streptococcal PJI that was managed with DAIR.
11                                        At implant, 99.5% of patients had a successful conversion of induced ventricular t
12                                     A total of 31.1% of all patients had an ophthalmic procedure, pars plana vitrectomy (
13                                           Eleven of the 434 patients had another infection within 6 months, but only 4 of
14                                                    Eligible patients had been enrolled at one centre in the AURA study, h
15 (median age, 63 years; 286 [32%] women) of the planned 1100 patients had been enrolled with follow-up for a median of 15
16  the current study had severe ocular abnormalities, and all patients had bilateral involvement.
17                                                    CLIPPERS patients had brainstem predominant perivascular gadolinium en
18 e BMI at surgery was 13.83 (SD 1.49) and 14 (88%) of the 16 patients had comorbid mood disorders, anxiety disorders, or b
19                                       One hundred and eight patients had cysts </=1.5 cm for more than 5 years of follow-
20 izumab; IQR 40.8-59.3 for chemotherapy), at which point 415 patients had died (214 in the chemotherapy group and 201 in t
21 g clones within the same patient, 30 (68%) of 44 individual patients had different levels of responses within the M1 and
22                Concluding, the present study found that OCD patients had difficulties with the deactivation of DMN even w
23                                                   Seventeen patients had either device thrombosis or ischemic stroke.
24                                            One-third of CSU patients had elevated levels of CRP.
25                                       A total of 131 of 740 patients had geriatric complications, and 114 of 740 patients
26                                              26 (39%) of 44 patients had grade 3 adverse events, but no grade 4 events we
27                                       Fifty-five percent of patients had grade 3 or 4 neurologic toxicities that complete
28                                                         Six patients had hepatitis B surface antibody (anti-HBs) titres a
29 edian number of previous lines of therapy was two (2-5), 38 patients had high-risk cytogenetics, 17 were unresponsive to
30            In the health registry study, moderate-severe AD patients had increased risk of antidepressant and anxiolytic
31                                    BAL fluid from asthmatic patients had increased TSLP but not IL-7 levels.
32 5 at the Massachusetts Eye and Ear Infirmary, 48 eyes of 44 patients had keratoprosthesis type II implanted by 2 surgeons
33                                        At follow-up, triage patients had lower health-related quality of life than an age
34                                      In contrast, 47.9% aCT patients had mastectomies with 7.3% BLM.
35                             More than one third of U.S. HIV patients had missed opportunities to initiate hepatitis B vac
36                             Reduced starting dose sorafenib patients had more Barcelona Clinic Liver Cancer stage D ( P <
37                                                AMR-positive patients had more dnDSA with a significant higher frequency o
38                                   Importantly, simultaneous patients had more renal vascular thromboses (4.4% vs 1.3% tx
39                                                ICD-positive patients had more severe depression, poorer sleep quality and
40                   Although we found evidence that high-risk patients had more to gain from treatment, we were unable to r
41                                                   Surviving patients had, on average, large improvements in health status
42 range 13-39) months before the study, the majority (88%) of patients had persisting symptoms compatible with heart failur
43                                      Eleven (4%) of the 274 patients had PHD after treatment with (177)Lu-DOTATATE: 8 pat
44                                             Two (1%) of 166 patients had serious adverse events; neither were considered
45                                                         BDG patients had significantly higher cerebral blood flow than di
46                            Compared with CLF patients, PCLD patients had significantly lower bilirubin and international
47             In the PRT setting of locally advanced RC, SRCC patients had significantly worse prognosis.
48 ction (stages I and II) was achieved in 32 patients, and 28 patients had stage III or IV disease.
49 of 740 patients had geriatric complications, and 114 of 740 patients had surgical complications; 187 of 740 patients (25.
50                                                  Twenty-two patients had XLP (9.7%; 10 male and 12 female patients), and

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。